CD24Fc
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD24Fc, covering 2022-04-04 to 2022-04-04. Get the full timeline:
Most recent: Clinical Trial Update: CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study [Phase 1, Phase 2]